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Illness Uncertainty in Parents of Children with Juvenile 
Idiopathic Arthritis
Caroline Pearce,1 Stanton Newman,1 and Kathleen Mulligan1,2
Objective. To gain a better understanding of uncertainty regarding the illness experienced by parents of children 
with juvenile idiopathic arthritis (JIA).
Methods. Parents/guardians of a child or young person (aged less than 18 years) diagnosed JIA were recruited 
in the United Kingdom via the National Rheumatoid Arthritis Society JIA group. Semistructured telephone interviews 
were conducted with the parents.
Results. Twenty parents took part, including 19 mothers and one father. Their children with JIA were mostly female 
(n = 15; 75%) with polyarticular arthritis (n = 12; 60%), averaged 8 years of age, and had been diagnosed for a mean 
of 3.7 (SD 2.3) years. Parents expressed uncertainty in the following five key domains: diagnosis, cause, symptoms, 
and prognosis; medical management; impact; parenting uncertainty; and awareness of JIA. All participants expressed 
uncertainty in at least four of the five domains. Although parents’ uncertainty in the early stages of the disease related 
to lack of information and understanding of JIA, much uncertainty could not be resolved by receipt of information. 
These included concerns about their child’s future and a lack of support with managing the emotional aspects of 
living with JIA.
Conclusion. We found that parents’ experiences of uncertainty went beyond dealing with the purely medical 
aspects of JIA. Provision of information about JIA, although essential, is not sufficient to help parents manage the 
considerable uncertainty they experience about many aspects of their child’s JIA. Identifying ways to incorporate 
support for coping with uncertainty into routine care will be an important way of supporting parents to care for their 
child with JIA.
INTRODUCTION
Juvenile idiopathic arthritis (JIA) is the most common rheu-
matological condition in childhood, with a global prevalence of 
32.6/100 000 (1). JIA comprises a group of heterogeneous dis-
eases of unknown cause (“idiopathic”) that begin before 16 years 
of age and cause inflammation of one or more joints, lasting at 
least 6 weeks (2). The current International League of Associations 
for Rheumatology classification of JIA specifies seven subtypes 
(systemic, oligoarticular, rheumatoid factor– negative polyarticu-
lar, rheumatoid factor– positive polyarticular, psoriatic; ethesitis- 
related, and undifferentiated), which are based on the number of 
affected joints and extra- articular involvement in the first 6 months 
of the disease (2). The robustness of this classification system 
has, however, been criticized (3,4), and its revision is underway (5).
There is currently no cure for JIA, and, without effective 
treatment, it can cause considerable pain, fatigue, disability, and 
impaired quality of life (6,7). Several pharmacological treatments 
are available that help to control the disease, including intraarticular 
glucocorticoids and disease- modifying antirheumatic drugs such 
as methotrexate and biological therapies, which have considerably 
improved JIA prognosis in recent decades. However, the medica-
tions do not work for everyone, and less than half of those with 
JIA achieve drug- free remission after 10 years (8). Often, children 
receive serial medications before finding one that works for them, 
during which time they can incur irreversible damage while expe-
riencing debilitating medication side effects (9,10), pain, and psy-
chosocial consequences of living with uncontrolled arthritis (11).
Living with JIA, in which the disease course and treatment 
effects are unpredictable, inevitably involves the experience 
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of uncertainty (12,13). For parents, being able to manage the 
stresses of their child’s illness and treatment is important in main-
taining their child’s wellbeing (14); however, uncertainty may limit 
the ability to cope (15). Higher levels of illness- related uncertainty 
have been found to be related to poorer wellbeing in both patients 
and carers in a range of long- term conditions (16– 21).
Two studies of uncertainty have been conducted with parents 
of children with juvenile rheumatic diseases (a majority of whom 
had JIA) and found that parent perceptions of illness uncertainty 
were related to parent and child distress (22,23). These stud-
ies reported illness uncertainty using a single dimension score, 
whereas research by Cleanthous et al in adult rheumatological 
disease (24) found that illness uncertainty is multidimensional, 
incorporating five domains, namely, uncertainty relating to symp-
toms and prognosis, medical management, self- management, 
impact, and social functioning. Health professionals can play an 
important role in helping parents to manage uncertainty, but, to 
do so, they require an understanding of parents’ experiences. This 
study aimed to gain an in- depth understanding of the uncertainty 
experienced by parents of children and young persons with JIA.
PATIENTS AND METHODS
Participants. Participants were recruited from the United 
Kingdom– based National Rheumatoid Arthritis Society JIA group 
(JIA- at- NRAS). Inclusion criteria were 1) parent/guardian of a 
child or young person (aged less than 18 years) who has a diag-
nosis of JIA and 2) the ability to speak English. Interviews were 
conducted with one parent/guardian per child. Participants were 
recruited using convenience sampling, and we sought to recruit 
both mothers and fathers.
Procedure. Ethical approval was granted by the City, Uni-
versity of London School of Health Sciences Research Ethics 
Committee (reference number Staff/16- 17/08).
The study was advertised via an email to members of the 
JIA- at- NRAS group, and information about the study was fea-
tured in their newsletter, website, and Twitter. The information 
contained a link to the participant information sheet and consent 
form and the contact details of the research team. For parents 
of a child aged 7 years or older, an information sheet for chil-
dren and young persons was also provided via the link, and par-
ents were asked to discuss the study with their child. Parents 
interested in taking part contacted the research team to arrange 
a convenient time for a telephone interview. As the interviews 
were conducted over the telephone, the consent procedure was 
audiorecorded.
Data collection and analysis. Semistructured telephone 
interviews were conducted by a postdoctoral research assistant 
experienced in qualitative methods (CP), using an interview topic 
guide informed by other research on illness uncertainty (24, 25) 
(Appendix A), which explored several areas of potential uncer-
tainty concerning their child’s illness, including symptoms, prog-
nosis, treatment, and impact. The interviews were recorded and 
transcribed verbatim. The transcripts were imported into NViVo, 
version 11, to facilitate analysis. Transcripts were analyzed using 
thematic analysis, which is a method for identifying, analyzing, and 
reporting patterns within data (26), and quotations that expressed 
aspects of uncertainty were coded. CP conducted preliminary 
coding of the interview data and developed an initial coding struc-
ture, which categorized codes into domains and subdomains. A 
second author (KM) read all transcripts and reviewed the initial 
coding structure along with the quotes coded within each domain/
subdomain. Thereafter, CP and KM discussed and revised the 
coding structure in an iterative process until consensus on the 
final structure and the list of uncertainty domains/subdomains 
was reached. During this iterative process, the developing cod-
ing structure was cross- referenced with the uncertainty framework 
developed by Cleanthous et al [24], and, where themes in this 
framework reflected the findings of the current study, these cate-
gories were applied to the data.
RESULTS
Twenty parents participated between November 2016 and 
January 2017; sample characteristics are shown in Table 1. 
Almost all were mothers (95%), and a majority were of White 
British  ethnicity (60%). Most (80%) were married/living with a part-
ner, and 65% had attended higher education. Just over half (55%) 
were in paid employment. The characteristics of the participants’ 
children with JIA are shown in Table 2. Most were female (15; 
75%), and 16 (80%) were less than 13 years old. The interview 
duration averaged 42 minutes, ranging from 17 to 80 minutes.
SIGNIFICANCE & INNOVATIONS
• Although uncertainty around JIA prognosis is inev-
itable, this study found that uncertainty permeates 
many other aspects of parenting a child or young per-
son with JIA. This included uncertainty about medical 
management, what impact JIA will have on the child 
and family, aspects of parenting a child with JIA, and 
a low level of awareness of JIA in the population.
• Our findings broaden conceptualizations of un-
certainty in relation to childhood chronic disease. 
Prior research on parental illness uncertainty has 
mainly focused on the domains we termed “diagno-
sis, cause, symptoms, and prognosis” and “medical 
management.” Other important domains identified 
in the current research concerned impact, parent-
ing uncertainty, and awareness of JIA.
• Information alone is not sufficient to enable par-
ents to manage uncertainty. Identifying ways to in-
corporate support for coping with uncertainty into 
routine care is required to support parents in car-
ing for their child with JIA.
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Uncertainty domains. Five domains and 19 subdomains 
of uncertainty were identified. All participants expressed uncer-
tainty in at least four of the five domains. Table 3 details the full list 
of uncertainty domains and subdomains, the number of partici-
pants who reported expressions of uncertainty within each of the 
subdomains, and illustrative quotes for each subdomain. These 
five domains captured the parents’ feelings of uncertainty around 
JIA, its treatment, and impact as well as uncertainty around their 
role as a parent in managing their child’s JIA and the social context 
of understanding of JIA. Each of the domains are described below.
Diagnosis, cause, symptoms, and prognosis. All par-
ticipants expressed some uncertainty regarding diagnosis, cause, 
symptoms, and prognosis. The sense of uncertainty experienced 
by parents of a child with JIA began with the diagnosis. Six parents 
expressed uncertainty over whether their child had been given the 
correct diagnosis. In particular, this uncertainty stemmed from 
doubts around the definitions of the subtypes of JIA and how the 
disease was diagnosed. This uncertainty over the diagnosis was 
also evident when some children had their diagnosis changed or 
faced the possibility of a changed diagnosis.
Although the aetiology of JIA is unknown, in trying to make 
sense of the diagnosis, many parents contemplated factors 
that may have caused the disease. Nine parents expressed 
uncertainty over the cause of JIA and how their child developed 
the disease. Within this, three parents expressed some feeling of 
uncertainty over the parent’s level of responsibility in causing their 
child’s JIA and initially having had feelings of blame that they may 
have done something to provoke the onset of the disease.
In the face of these feelings of uncertainty, parents would at 
times attempt to attribute the cause of JIA to something, such 
as a virus. The fact there appeared “no rhyme or reason” for JIA 
starting meant many parents had difficulty accepting the diagno-
sis. One way the parents managed this uncertainty over the cause 
and diagnosis was to, as one parent described, remain in a state 
of “denial” over whether their child actually had JIA and view the 
onset of the disease as a “one off.”
Uncertainty around symptom interpretation was a strong 
theme throughout the interviews and was expressed by 19 partic-
ipants. This uncertainty was exacerbated when the child was too 
young to be able to articulate how they were feeling. In addition, 
parents described the difficulty in distinguishing their child’s health 
status and symptoms from normal child behaviour, thereby mak-
ing it difficult to judge whether their child was well or ill. When the 
child had a comorbid condition, it could increase uncertainty when 
interpreting symptoms as JIA related. Before a diagnosis, many of 
the parents described being faced with seemingly unexplainable 
symptoms and would attribute symptoms to JIA retrospectively.
Uncertainty over the prognosis of JIA was a strong theme in 
all of the interviews. This could be linked to the uncertainty over 
the diagnosis, which some considered made it difficult to pre-
dict the progression of the child’s health. Parents described how 
they found it hard to deal with not knowing what was going to 
happen in the future. As one parent described it, the experience 
of having a child with JIA was “a very unpredictable journey,” in 
which the child could be fine one day and unwell the next. Par-
ents described the cyclical nature of JIA and how this influenced 
their feelings of uncertainty. They tended to oscillate between 
feelings of hope at the chance of recovery, which was experi-
enced during periods of remission, and then uncertainty as to 
whether the JIA might ever go away if the child experienced 
a flare. Parents used words such as “cyclical,” “cycle,” “roller-
coaster,” and “fluctuate”’ to capture the sense of uncertainty 





Age, mean (SD) 40.95 (5.7)
Ethnicity, n (%)
White British 12 (60)
White European 3 (15)
Mixed (White and Black) 1 (5)
Mixed (White and Asian) 1 (5)
Mixed (White and Maori) 1 (5)
Mixed (not specified) 1 (5)
Asian (Chinese) 1 (5)
Marital status, n (%)
Married/living with partner 16 (80)
Divorced 3 (15)
Single 1 (5)
Employment status, n (%)
Full- time 4 (20)
Part- time 7 (35)
Full- time homemaker/carer 8 (40)
Student 1 (5)
Education (highest qualification), n (%)
A levels*/vocational level 3 or equivalent 5 (25)
Undergraduate diploma/level 5 or equivalent 1 (5)
Higher education 13 (65)
Other qualifications, level unknown 1 (5)
* A levels are national exams taken at an approximate age of 18 years 





Age, yr, mean (SD) 7.95 (3.9)
JIA subtype, n (%)
Polyarthritis 12 (60)
Oligoarthritis 4 (20)
Extended oligoarthritis 3 (15)
Systematic Onset 1 (5)
Years since diagnosis mean (SD) 3.7 (2.3)
Current medication, n (%)
DMARDs 5 (25)
Biologics 2 (10)
DMARD and biologic treatment 8 (40)
Steroids 1 (5)
None 4 (20)
DMARD, disease- modifying antirheumatic drug; JIA, juvenile 
idiopathic arthritis.
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Table 3. Uncertainty domains and subdomains





Diagnosis Unsure whether 
diagnosis is correct
6 “She’s got Oligo JIA but yesterday, [at clinic] (…), they actually changed 
it to Poly. I think the whole uncertainty thing comes in. Every time 
we go somewhere it changes slightly.”
Cause Uncertainty around the 
cause of JIA
9 “So I was blaming myself for a long time for her illness. That [there] 













19 “In retrospect she had a little episode with a joint in her foot (…) a few 
months before with her foot where it had swollen up but we 
thought she’d injured herself and didn’t do anything about that 
really, just waited for it to go away.”
“Is he having tantrums because something’s hurting him and he can’t 
communicate it? Or is he having tantrums because he’s a toddler 
and that’s what they do? Or because he’s got a cold and it’s nothing 
to do with arthritis?”
Interpretation of 
health status
Judging how well child is 12 “Sometimes she’ll be reluctant to tell us, I’ll ask are you sore? Have 
you got a sore or something? No. I’m all good. (…) So I say, you’ll tell 
daddy if you’re sore eh? No. And so it can be a little bit difficult to 
say is something going on or not.”
Prognosis Unsure of future 
progression of the 
disease
20 “And I’m scared will it extend further, is it somewhere else that we 
don’t know about (…) I’m scared of what the future brings, (…) will he 




Treatment Uncertainty over 
treatment regime: 
necessity, changes to 
medication, side 
effects
20 “I don’t know how long this one is going to work for and indeed when 
this stops working I don’t know if there are any other options. I 
don’t know what the next stage would be.”
“If he’s been in remission for at least a year they will start talking 
about coming off and when you come off you’re back in the 
wilderness and then you don’t know if it’s going to come back.”
Trust in doctor Medical professional 
knowledge and ability 
to help with condition. 
Doctors’ uncertainty 
around initial diagnosis 
and prognosis
13 “I have to trust in the consultant who’s looking after him and the 
nurse practitioner because they know what they’re doing and I 
don’t and I have to put all my trust in them, is how I see it because 
I’m not an expert and they are and I don’t particularly like that I 
have to say because you don’t always know or feel, what I’m saying 
is you don’t always know if some things are done because it’s cost 
effective rather than the best thing.”
“But yeah at the same time I’ve come to realise all these years that 
even the consultants they don’t really know. (…) they give you 
something and some kids start on something and then three 
months down the line they realise it doesn’t work and then they 









11 “The part that was also overwhelming is to understand how the NHS 
is working and the different parts of it.”
“The emotional side of it and coping with injections and needle 
phobias and how you manage being different and all that kind of 
stuff, I don’t think there’s nearly enough done about that.”
Transitioning to 
adult care
Uncertainty around child 
transitioning to adult 
care
2 “The other concern as well is of course that she will need to be, have 
some sort of transitional treatment by, there is a transition 
consultant who deals with adolescents. So that would be good to, 
we don’t know how to get into that (…)”
Impact 16





impact of JIA on child’s 
personality and 
character.
15 “I wonder how she will accept the disease as she comes to know 
more about it and what her reaction to the disease will be. (…) she’s 
grown up with it, it’s all she’s known, but as she becomes older I 
just wonder if she’s bitter or resentful.”
“Yeah, I worry that he won’t be able to make friends in the same way 
and he’ll be ostracised because of it because he’s a boy and boys 
do sport.”
Forward planning Ability to plan for 
short- and long- term 
events
6 “We’ve got two weeks holiday booked (…) in the summer and we 
cannot plan, there’s nothing you can plan, (…) we don’t know 
whether we’ll have to find local hospitals or there’ll be medication 
down there and there’s, it just does affect everything.”
Impact on family 
members
Impact on family as a 
whole and other 
children
9 “But balancing the needs of a child with what is I guess a long- term 
unpredictable condition with your other child or children and 
managing that… It is [settled] now and that’s, but it still has a strain 
on us as a family I think.”
 (Continued)
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over the prognosis, which included much anticipation and wait-
ing, either for remission or another flare. A sense of hope allowed 
the parents to try to remain positive despite the uncertainty, for 
instance the hope that their child would recover or that soon 
a cure would be discovered. However, the fear that their child 
would enter adulthood and continue to struggle with symptoms 
of the disease was a real concern and a source of uncertainty 
for many of the parents.
Medical management. The role of medical management 
was a key theme in the parents’ interviews, in particular uncertainty 
around treatment for JIA, which was expressed by all 20 partic-
ipants. Two parents expressed uncertainty around the necessity 
of the treatment, for example, if their child was on the most 
appropriate treatment or whether medication was still neces-
sary once symptom- free. Twelve parents expressed uncertainty 
and worry about whether their child’s current medication would 
continue to work and what would happen if it stopped working. 
Although hoping that their child could eventually come off medica-
tion, three parents also expressed the fear about the medication 
being stopped, with the possibility that the disease could flare but 
the medication not work when restarted.
Sixteen parents expressed concern about the side effects 
of medication. These included the immediate impact of the treat-
ment on their child’s immune system and potential longer- term 
impact, such as effects on fertility. Further, parents had difficulty 
in identifying the impact of the treatment on their child’s normal 
development. There was also uncertainty around distinguishing 




Coping Ability to cope physically 
and emotionally with 
demands, and feelings 
of powerlessness
12 “I’m assuming I’ll find a way to cope. I try not to think about not coping 
because then I might not cope.”
“You love your daughter, very caring, very close bond and then when 
you see her in pain you feel powerless about that. So 
powerlessness I think is one of the things that I struggle with. You 
think actually, I can, you can do things to make her more 
comfortable and you still feel this level of powerlessness.”
Managing child’s JIA Uncertainty around how 
best to manage child’s 
JIA including symptom 
management, 
managing medication, 
child’s behaviour and 
emotional wellbeing, 
managing JIA into the 
future including child’s 
medication 
self- management
12 “You don’t want to be overprotective, but you want to make sure you 
care for her, given her JIA, and at the same time you’re parenting 
and trying to set boundaries. And, so definitely I think overall your 
parenting is influenced.”
“On the one hand I don’t want to allow her to be rude and 
uncooperative but on the other hand I don’t want to discipline her 
for those things if it’s a manifestation of her trying to express how 
she’s feeling if she’s feeling sick or she’s feeling tired or in pain.”
Role requirements Unsure of role as parent 
and carer and role 
expectations
4 “I think my role as a mum has changed into more of a medical role 
sometimes. I don’t want her to resent me as she gets older for 
being the one that’s always holding her down for things. That’s my 






13 “Trying to make the best decisions I think on her behalf I think it 
would be easier if you’re making the decision for yourself. It’s just 
the responsibility of doing the right thing and safeguarding her 
emotional wellbeing as well as her physical wellbeing.”
Awareness of JIA 19
Social awareness Understanding among 
family, friends, and 
others of the condition 
and support received, 
invisibility of condition
18 “A lot of people still don’t understand it, because we still get the 
‘What, children get arthritis? It cannot be, are you sure? It’s an old 
people thing.”
“School again, it’s a bit like talking to your family, it’s quickly brushed 
under the carpet, they don’t really want to know, but they don’t 
understand.”
Gaps in information Areas parents feel are 
missing from JIA 
information, lack of 
awareness prior to 
diagnosis
11 “I had to find out about disability benefits and fight very hard for it 
and all the other things that I’m entitled to. You don’t get given that 
information you have to find it for yourself really.”
“Perhaps there have been times when I would have liked more 
information and I didn’t accept it. But I see, I get now why there isn’t 
more out there, because it just, they can’t tell you facts and 




How confident parents 
feel about the 
information they 
receive
4 “There’s also some misinformation and there’s also a lot of American 
information, which doesn’t necessarily apply to the treatments that 
we have over here. So, I think you can go a bit wrong with some of 
the Googling and I think I did at the beginning, trying desperately to 
understand it all.”
JIA, juvenile idiopathic arthritis.
Table 3. (Cont’d)
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the side effects of the treatment from the symptoms of the dis-
ease itself.
Parents mostly felt well supported by their medical teams, 
and although they described wanting a clearer picture from med-
ical professionals around the prognosis, they did acknowledge 
that this is not possible. Ten of the parents described uncertainty 
among doctors before receiving a diagnosis, where there was 
often a long process before symptoms were identified as JIA. 
This was, for some of the parents, a frustrating time of feeling 
dismissed or “fobbed off” by health care professionals.
Almost all parents reported receiving very good care from 
their clinical teams, and they were an important source of support 
when a parent felt uncertain about an aspect of their child’s illness. 
However, several had faced uncertainty when trying to navi-
gate health services early on in their child’s illness. Gaps in care 
included lack of availability of support for dealing with the emo-
tional or psychological impact on the child and family as a whole, 
which was mentioned by two parents, and another referred to an 
inability to raise all her concerns with the rheumatologist in front 
of her child. In parents whose children were in their teens, this 
uncertainty around the support from hospitals and medical pro-
fessionals also extended to uncertainty about how and when their 
child would transition to adult care.
Impact. Besides uncertainty relating to the general progno-
sis, reported above, 16 participants expressed uncertainty and 
worry regarding the impact JIA would have on their child. This 
included their child’s future emotional wellbeing and social func-
tioning and how their child might cope without them as they grow 
older. Parents had concerns about whether their child would be 
able to engage with school activities, for example, sports classes. 
They also highlighted uncertainty about the emotional impact of 
JIA, including the experience of having medical treatment from 
a young age. The uncertainty of the emotional impact was also 
emphasized if the child was unable to describe their emotions to 
their parent. Parents had concerns about how their child will feel 
as they get older and begin to understand the disease. As many of 
the children were diagnosed at a young age, parents mentioned 
uncertainty around the impact of JIA on their child’s personality 
and character. Some parents contemplated the extent to which 
JIA may have exacerbated mood swings or toddler “tantrums” or 
affected psychological wellbeing.
Forward planning was also difficult because of the unpredict-
able nature of JIA. Parents described how JIA could affect the 
ability to plan for short- and long- term events. They also spoke 
of the impact that having a child with JIA had on the family as a 
whole and concerns about the impact on other siblings.
Parenting uncertainty. All participants expressed some 
uncertainty around their role as a parent and carer for their child 
and their ability to cope and manage their child’s JIA. Some 
described difficulty in distinguishing their roles as parent and carer 
and feeling unsure whether they were doing a “good job.”
Twelve parents described their worries in physically and 
emotionally coping with being a parent of a child with JIA. They 
described coping on a day- to- day basis rather than thinking too 
far into the future. Indeed, some parents mentioned they tried not 
to think about future problems in order for them to cope with the 
present. This uncertainty about the ability to cope also caused 
feelings of powerlessness. Parents felt that JIA was “calling the 
shots” and struggled with seeing their child in pain and being una-
ble to remedy it. Specifically, the parents were uncertain about 
how to manage different aspects of their child’s illness, including 
how to manage pain and treatment as well as their child’s emo-
tional wellbeing. Many of the parents expressed a sense of doing 
the best they can but feeling unsure whether they were doing 
enough.
Another dimension the parents highlighted was uncertainty 
about how to manage their child’s behaviour, for example, setting 
the right boundaries while taking their child’s illness into consid-
eration. Parents also felt uncertain about their role in managing 
their child’s illness as they entered adolescence and adulthood. 
There was some concern about what would happen when the 
child would come to manage their treatment themselves, as most 
parents still had control over their child’s treatment regime.
Thirteen parents described uncertainty when making deci-
sions about their child’s care, particularly when making decisions 
on medication and treatment, which could relate to commencing, 
changing, or coming off medication. For parents, the responsibility 
of their child’s care could feel great. They described a process 
of continually weighing up the options before making a decision. 
However, a number of parents did note that though they struggled 
initially with making decisions, their confidence in their own judge-
ment had grown over time.
Awareness of JIA. The uncertainty the parents expe-
rienced was set within a broader context of a lack of under-
standing and awareness about JIA, which was mentioned by 19 
participants. Seven remarked that they had little awareness and 
knowledge of JIA before their child was diagnosed. They also 
described a lack of understanding among friends and family and 
felt people did not appreciate the realities of living with JIA. This 
was made more difficult by the invisibility of the condition, with 
parents describing JIA as a “hidden disability.” The parents found 
that other people did not acknowledge the seriousness of the 
disease if they saw the child looking well. Four parents men-
tioned problems with accessing support from their child’s school, 
where they faced a lack of understanding of JIA. Related to this, 
17 of the parents mentioned the use of peer support, mostly 
via an online social media group, that provided mutual under-
standing and feelings of reassurance as well as practical help 
and information.
PEARCE ET AL 256       |
Parents noted some gaps in knowledge; however, they 
acknowledged that these were due to a general uncertainty 
around aspects of JIA, such as prognosis, rather than being una-
ble to access available information. All except one participant felt 
they had received sufficient disease information; this came from a 
range of sources, including the hospital team, relevant charities, 
the internet, and other parents. More disease information was not 
necessarily viewed as helpful to the parents, as it was felt that 
such information did not reduce feelings of uncertainty. Three par-
ents actually felt they had received too much information and felt 
overwhelmed by it. Specific areas on which parents wanted more 
information and support were on managing the day- to- day prob-
lems and the emotional side of the disease for parents and chil-
dren (n = 5) and information on accessing disability benefits (n = 2).
DISCUSSION
To date, there has been little research on the experiences 
of parents of children with JIA. Although uncertainty around JIA 
prognosis is inevitable, this study found that uncertainty perme-
ates many other aspects of parenting a child or young person with 
JIA. We identified the following five domains of uncertainty: diag-
nosis, cause, symptoms, and prognosis; medical management; 
impact; parenting uncertainty; and awareness of JIA.
Other studies of uncertainty in parents of children with rheu-
matic diseases (22,23) have used the Parental Perceptions of 
Uncertainty Scale (PPUS) (27), which covers some, but not all, 
of the domains of uncertainty identified in the current study. The 
PPUS focuses mainly on uncertainty in the domains that we 
termed “diagnosis, cause, symptoms, and prognosis” and ‘med-
ical management’ (although it does not include questions on 
uncertainty around making decisions relating to their child’s care, 
which was expressed by participants in the current study). We 
found that parents’ experiences of uncertainty went beyond deal-
ing with the purely medical aspects of JIA, which has implications 
for how parents are able to support their children in managing their 
JIA. Corbin and Strauss (28) proposed that living with a chronic 
disease involves the following three key tasks: medical man-
agement (eg, taking medication and attending hospital appoint-
ments), adapting life roles such as school and relationships to the 
demands of the condition, and managing the emotional conse-
quences of having a chronic disease. Parents’ reports of uncer-
tainty spanned these three tasks, highlighting a need for support 
that goes beyond the provision of information about the disease 
and its treatment.
Some of the uncertainty experienced by parents may be 
helped by a broader awareness of JIA in the population. A lack of 
awareness, both among the participants themselves and among 
nonspecialist health professionals, was a source of uncertainty 
during the early stage of the disease before diagnosis. Feelings 
of confusion, anxiety, and frustration with the health care sys-
tem during this period have also been reported elsewhere (13). A 
recent United Kingdom study reported that the median time from 
symptom onset to first pediatric rheumatology appointment was 
23.6 weeks (interquartile range 12.3- 50.4)(29) and did not vary 
significantly across the 10- year study period. The authors referred 
to several steps that have been taken in recent years to try to 
raise awareness of JIA in all doctors, including training for medical 
students and education for primary- care physicians and pediatri-
cians, but they recognized a continued need for efforts to assist 
health professionals in the early recognition of JIA. They also rec-
ommend targeted education for schools, nurseries, and health 
visitors. A lack of awareness among the general population con-
tinued to be an issue for parents after diagnosis because teach-
ers, family, and friends did not always appreciate the difficulties 
of living with JIA. Recent campaigns such as the World Young 
Rheumatic Diseases Day (30) may help to raise awareness of JIA.
The study findings highlight the important role that health 
professionals played in helping parents to manage illness uncer-
tainty. Once a diagnosis was received, parents sought out and 
received information about JIA from their clinical teams. They also 
reported seeking information and support from clinicians as new 
issues arose. Almost all parents reported having very supportive 
clinical teams and having received sufficient information about JIA 
and medication.
Although some aspects of parent uncertainty can be allevi-
ated by attending to unmet information needs, uncertainty man-
agement theory states that the relationship between information 
and feelings of uncertainty is complex (31), and, although infor-
mation can help to reduce uncertainty, it may also maintain or 
even increase uncertainty by introducing new concerns or ques-
tions about the illness (32). The uncertainty of JIA is an ongoing 
challenge for parents throughout their child’s illness, and new 
issues arise as their child develops, many of which cannot be mit-
igated by the provision of information. For example, some parents 
expressed uncertainty and worry about the extent of the emotional 
impact that JIA had or could have on their child and highlighted a 
lack of support for their child in dealing with the emotional side of 
living with JIA. This issue has also been identified by young peo-
ple with rheumatic conditions who felt that psychosocial research 
should be given greater priority (33).
Parents also experienced uncertainty in their role as carer, 
which has been identified by other carers of those with both adult 
(25) and childhood illnesses (34,35). This highlights the impor-
tance of supporting parents in managing their uncertainty both 
for their own wellbeing and for the wellbeing of their child. Young 
people with rheumatic conditions have also recognised the effect 
that their illness has on their parents and the need for research into 
how their families could be better supported (33). Many parents 
turned to an existing online parent group, which they found help-
ful, but more routinely available support from health professionals 
for psychological issues requires greater consideration.
Although health professionals cannot eliminate all uncer-
tainty about JIA, they can help parents to manage it. For example, 
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the development of decision aids (36) may help parents manage 
the uncertainty experienced around treatment changes. There 
is also evidence that illness uncertainty is modifiable; research 
has found that parents who use more positive coping styles 
experience less uncertainty (21), suggesting that interventions to 
teach coping strategies may help to alleviate some of the stress 
of illness uncertainty. Fedele et al (37) developed an interven-
tion to help mothers of children newly diagnosed with cancer to 
cope with the uncertainty of their child’s illness and treatment. 
The intervention, which included sessions on communication 
skills, methods of coping, problem- solving strategies, and how 
to use social support effectively (38), was found to have a sig-
nificant benefit on child adjustment (37). The intervention of Hoff 
et al (39) for parents of children newly diagnosed with type 1 
diabetes included techniques to manage uncertainty, such as 
information, role clarification, and training in problem- solving 
and communication skills. Although the level of uncertainty did 
not change, parental distress reduced over time in the interven-
tion group but not in the control group, suggesting that parents 
became better at coping with the uncertainty. Maternal ratings 
of their child’s behaviour also improved in the intervention group. 
Identifying ways to incorporate support for coping with uncer-
tainty into routine care would be an important way of supporting 
parents to care for their child with JIA.
This study had a number of limitations. Only one father 
was recruited to the study; the absence of fathers in research 
about children’s illness is widely recognized (40). We recruited 
by advertising for volunteers through an arthritis charity, but 
it may be that a more targeted approach is required to ensure 
that fathers are recruited. Ours was a highly educated sample 
who may be better equipped than many to navigate health and 
other services relating to chronic illness. For example, although 
only two parents spoke about uncertainty relating to claiming 
disability benefits, others may require more support with this 
issue. A majority of parents in the current study had children with 
JIA who were less than 12 years old. Fedele et al (23) found 
that the association between parental uncertainty and parental 
distress was greater in parents of older children and that paren-
tal uncertainty was related to increased child depressive symp-
toms in older, but not younger, children. It may be that other 
issues around uncertainty would have been identified if we had 
recruited more parents of older children. As this is a qualitative 
study with 20 parents, we were not able to examine the strength 
of the relationship between uncertainty and outcomes such as 
psychological wellbeing. To do so will require the development 
of a measure that captures the breadth of parental uncertainty 
identified in the current study.
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Appendix A: Interview topic guide
Thank you very much for your interest in the project and giving 
your time to take part. The interview will ask about your experi-
ences as a parent of someone with JIA and what you understand 
and think about JIA. Do you have any questions before we start? I 
just want to emphasise that you can skip any questions you would 
prefer not to answer or end the interview at any time you wish. Are 
you happy to begin?
Can I begin by asking your child’s age and which type of JIA he/she has? 
(prompt with names of the different types of JIA if necessary).
Symptoms and Diagnosis
Could you tell me about when s/he first started showing symptoms? 
How was s/he diagnosed with JIA?
What kind of symptoms has s/he experienced since then?
Prompts Is it clear which symptoms are related to JIA? Are symptoms 
predictable?
Treatment
What treatment is your child receiving for their JIA? (prompt with different 
types of treatment e.g. medication, joint injections, physiotherapy).
Prompts Understanding of how the treatment manages their JIA? Any 
concerns about the treatment/healthcare they receive?
Impact
How do you think JIA has affected your child? Might it change in the 
future?
Prompts Physically, socially, emotionally? (school, friendship groups, fam-
ily relations, growth, ability to participate in sports, activities, mood)
How has your child’s JIA affected you? Might it change in the future?
Self- management
[Depending on age of child] What kind of things can your child do to help 
manage their JIA themselves? Are there things they should avoid doing?
Can you tell me about your role in caring for a child/young person with 
arthritis?
Prompts How easy/difficult do you find it? How confident do you feel to 
make decisions about your child’s care?
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Social support
Do you receive support from others? Is it reliable?
Do you talk about your child’s JIA to others/friends/family?
How did your family respond to your child being diagnosed with JIA?
Information and understanding
Where have you obtained most information about JIA? Do you feel you re-
ceive enough information? Are there aspects that you feel uncertain about?
Overall, how well do you feel that you understand your child’s arthritis? 
…and their treatment?
That is all of the questions I had for you – are there any other as-
pects of having a child with JIA that we haven’t discussed that are 
important?
Thank you very much for taking part.
